Crane Company (CR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
1 Apr, 2026Executive summary
Annual Meeting scheduled for April 28, 2025, with voting on director elections, auditor ratification, and executive compensation approval.
Strong 2024 financial performance, with significant sales and margin growth in both Aerospace & Electronics and Process Flow Technologies segments.
Strategic actions since 2022 included major acquisitions, divestitures, and the completion of a corporate separation, resulting in a 167% increase in combined equity value since 2020.
Board and management focused on portfolio simplification, growth investments, and operational excellence.
Voting matters and shareholder proposals
Shareholders will vote on electing nine directors for one-year terms, ratifying Deloitte & Touche LLP as independent auditors for 2025, and approving executive compensation in a non-binding advisory vote.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Board consists of nine members, eight of whom are independent; diversity in gender, ethnicity, and experience is emphasized.
Lead Independent Director role established in 2024 to ensure independent oversight under a combined Chairman/CEO structure.
Annual board and committee self-evaluations, strict overboarding and retirement policies, and majority voting with resignation policy for directors.
Board committees (Audit, Compensation, Nominating/Governance) are fully independent and meet NYSE requirements.
Latest events from Crane Company
- Record Q2 sales, margin expansion, and raised EPS guidance driven by strong demand and acquisitions.CR
Q2 2026 - Record adjusted EPS and 24.9% sales growth drove raised full-year guidance and strong M&A capacity.CR
Q1 2026 - Annual meeting to vote on directors, auditor, and pay, with online and eco-friendly options.CR
Proxy filing - Record results, strategic acquisitions, and strong governance drive value and growth.CR
Proxy filing - Record 2025 EPS growth, robust M&A, and 10% EPS growth guidance for 2026.CR
Q4 2025 - Adjusted EPS up 27% on strong sales; guidance raised and PSI acquisition progressing.CR
Q3 2025 - Q2 sales up 9.2%, EPS up 24%, guidance raised, and $1.06–$1.15B PSI acquisition announced.CR
Q2 2025 - Q1 2025 delivered strong EPS and sales growth, with robust outlook and active M&A pipeline.CR
Q1 2025 - Q4 adjusted EPS up 58%, 2025 guidance raised, and dividend increased 12%.CR
Q4 2024